Catalent’s Delara Motlagh joins experts discussing advancements that bridge the gap from cell collection to commercialization, accelerating critical therapies to patients. Discover what’s next for cell and gene therapy manufacturing in this podcast! #CellTherapy #GeneTherapy #PatientFirst https://ow.ly/PNk150U9YUV
Catalent Pharma Solutions
Pharmaceutical Manufacturing
Somerset, NJ 273,769 followers
more products. better treatments. reliably supplied. ™
About us
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.™ Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact.
- Website
-
https://www.catalent.com
External link for Catalent Pharma Solutions
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Somerset, NJ
- Type
- Public Company
- Founded
- 2007
- Specialties
- Analytical Chemistry, Clinical Supply, Biotech, Pharmaceutical Supply Chain, Biologics, Formulation Development, Drug Delivery, Clinical Packaging, Dose Form Manufacturing, Gene Therapy, Vaccine Production, Pharmaceutical, Drug Development, Cell Therapy, Biopharmaceutical, and Innovation
Locations
Employees at Catalent Pharma Solutions
Updates
-
Explore the critical aspects of lipid-based formulations, from preclinical studies to clinical applications and delve into the various mechanisms through which these formulations exert their effects. Watch this webinar now. https://ow.ly/LRjx50UoJ2Q
-
-
We are excited to share that we completed our transaction with Novo Holdings! As a private company with Novo Holdings’ partnership and support, we are well-positioned to deliver unparalleled outcomes for our customers and the patients we serve. Across our remaining network of more than 40 global sites, we will continue to provide our customers with the latest technology and capabilities and partner with them to expand patient access to much-needed treatments and cures. The entire Catalent team remains focused on our mission to develop, manufacture and supply products that help people live better, healthier lives. Learn more about our announcement here: https://ow.ly/rH0c50Utlio
-
-
Catalent’s universal iPSC platform promises to bring advanced therapies to patients faster and more efficiently. Learn how we’re paving the way toward more accessible treatments with this Q&A from Catalent’s own Boris Greber. #iPSC #PatientFirst #Innovation https://ow.ly/IMum50UsWWa
-
-
Prefilled syringes (PFSs) are becoming the go-to for new injectable biologics. Transitioning from vial to PFS comes with its challenges. This article highlights the benefits and explores solutions for overcoming the pitfalls. https://ow.ly/nKTR50UlYzS
-
-
Timely progression of a drug candidate into clinical trials is critical for pharmaceutical companies seeking to bring new products to the market. Download this ebook to explore valuable tips for streamlining CMC development strategy and navigating early and mid-stage clinical trials. https://ow.ly/bhQH50Usfe7
-
-
Lack of preparation for scale-up can often cause major time delays, increased costs and rework. Download this eBook for insights on key approaches for preparing your small molecule program for long-term success. https://ow.ly/qTO850Usaxx
-
-
Get insights on how embedding Quality by Design (QbD) into your drug product manufacturing process can help accelerate timelines, reduce costs, and ensure product safety and efficacy. #CDMO #biologicsmanufacturing #QBD https://ow.ly/oRT450UrOE6
-
Catalent’s GMP-compliant processes ensure safety and consistency in iPSC production. Discover how advanced differentiation methodologies are raising industry standards: https://ow.ly/2btV50UleXx #GMP #CellTherapy #QualityControl #Catalent
-